跳至主要内容
临床试验/NCT01941238
NCT01941238已完成不适用

Incidence of Hypoglycemia During Ramadan in Patients With Type1 Diabetes on Insulin Pump Versus Multi-dose Insulin Injection

Reem Mohammad Alamoudi1 个研究点 分布在 1 个国家目标入组 142 人开始时间: 2013年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
142
试验地点
1
主要终点
Incidence of hypoglycemia

研究概览

简要总结

Managing patients with type1 diabetes when fasting Ramadan is very challenging. Insulin pump offers the advantage of flexibility and precision to administering insulin and has been proven to reduce severe hypoglycemia compared to multi-dose injection (MDI). However, there are extremely limited studies on the difference between insulin pump compared to MDI on the incidence of hypoglycemia and other acute complications during fasting Ramadan

The investigators hypothesized that insulin pump would be associated with less hypoglycemic events during fasting Ramadan compared to MDI without deterioration in glycemic control. Results of this study are descriptive but will fill a current gap in knowledge and may contribute to development of future guidelines for the management of type1DM during Ramadan.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
14 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥14 years
  • Patients on insulin pump (more than 3 months)
  • Patients on MDI (glargine or detemir combined with aspart or lispro) regimen
  • Diagnosis of type 1 DM of more than 6 months.
  • Willing to do Self Monitoring Blood Sugar (SMBG)
  • Have no other contraindication to fast

排除标准

  • Patient with renal or hepatic impairment
  • Patient with diagnosed adrenal insufficiency
  • Any diagnosed psychiatric disease
  • Can not do SMBG

结局指标

主要结局

Incidence of hypoglycemia

时间窗: 5 weeks

Rates of hypoglycemia during fasting ramadan in insulin pump users and MDI users \[Hypoglycemia defined as blood glucose level ≤ 70 mg/dl ( 3.9 mmol/l)\]

次要结局

  • Number of fasting days lost(5 weeks)
  • Glycemic control(Two (2) months)
  • Rate of acute complications(5 weeks)
  • overnight hypoglycemia(5 weeks)

研究者

发起方
Reem Mohammad Alamoudi
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Reem Mohammad Alamoudi

Consultant Endocrinology

King Abdullah International Medical Research Center

研究点 (1)

Loading locations...

相似试验